Trials / Completed
CompletedNCT01515891
Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites
An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites Following a Single-dose Oral Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Bial - Portela C S.A. · Industry
- Sex
- Male
- Age
- 40 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To determine the absorption, metabolism and excretion of BIA 9-1067.
Detailed description
Monocentre, open, non-placebo-controlled, single-group, single-dose study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BIA 9-1067 | 90 µCi (3.33 MBq) \[14C\]-labeled of 100 mg BIA 9-1067 (single-dose). |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2009-06-01
- Completion
- 2010-09-01
- First posted
- 2012-01-24
- Last updated
- 2015-01-09
- Results posted
- 2015-01-09
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01515891. Inclusion in this directory is not an endorsement.